Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TARAProtara Therapeutics, Inc.

Nasdaq · CIK 0001359931
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts427

Identity from submissions API

NameProtara Therapeutics, Inc.
CIK0001359931
TickersTARA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN204580525
LEI—
Fiscal year end1231
State of incorporation—
Phone646-844-0337
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Protara Therapeutics, Inc. (2020-05-13T04:00:00.000Z → 2026-11-16T05:00:00.000Z)
  • ArTara Therapeutics, Inc. (2019-11-29T05:00:00.000Z → 2020-04-23T04:00:00.000Z)
  • PROTEON THERAPEUTICS INC (2006-04-14T04:00:00.000Z → 2019-12-31T05:00:00.000Z)
Business address
345 PARK AVENUE SOUTH
3RD FLOOR
NEW YORK
NY
10010
NY
Mailing address
345 PARK AVENUE SOUTH
3RD FLOOR
NEW YORK
NY
10010
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

812 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000267 005-88372 261558447 34 13201
2026-11-06 10-Q QUARTERLY REPORT 0001213900-26-116612 001-36694 261529452 34 5500540 1 1
2026-11-06 8-K CURRENT REPORT 2.02,9.01 0001213900-26-116607 001-36694 261529444 34 298259 1 1
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000205 005-88372 261271754 34 13525
2026-08-11 S-8 REGISTRATION STATEMENT 0001213900-26-087781 333-298226 261263401 33 232079 1 1
2026-08-11 10-Q QUARTERLY REPORT 0001213900-26-087508 001-36694 261260706 34 5613803 1 1
2026-08-11 8-K CURRENT REPORT 2.02,9.01 0001213900-26-087506 001-36694 261260691 34 288623 1 1
2026-07-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-081389 005-88372 261160480 34 18992
2026-07-01 4 PRIMARY DOCUMENT 0001213900-26-074238 16803
2026-06-29 8-K CURRENT REPORT 5.02 0001213900-26-073184 001-36694 261136723 34 189612 1 1
2026-06-29 144 xsl144X01/primary_doc.xml 0001950047-26-006626 001-36694 261136559 33 5027
2026-06-16 4 PRIMARY DOCUMENT 0001213900-26-069250 5964
2026-06-16 4 PRIMARY DOCUMENT 0001213900-26-069249 6014
2026-06-16 4 PRIMARY DOCUMENT 0001213900-26-069248 5962
2026-06-16 4 PRIMARY DOCUMENT 0001213900-26-069247 5992
2026-06-16 4 PRIMARY DOCUMENT 0001213900-26-069246 6058
2026-06-16 4 PRIMARY DOCUMENT 0001213900-26-069245 5935
2026-06-16 4 PRIMARY DOCUMENT 0001213900-26-069244 5940
2026-06-16 4 PRIMARY DOCUMENT 0001213900-26-069243 5934
2026-06-15 8-K CURRENT REPORT 5.07 0001213900-26-068774 001-36694 261090781 34 212481 1 1
2026-06-03 4 PRIMARY DOCUMENT 0001213900-26-064792 5283
2026-05-28 424B5 PROSPECTUS SUPPLEMENT 0001213900-26-062153 333-295862 261036702 33 474910
2026-05-22 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001748 333-295862 261015769 33 1955
2026-05-20 CORRESP filename1.htm 0001213900-26-059250 5474
2026-05-19 UPLOAD filename1.pdf 0000000000-26-005137 333-295862 150157
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000151 005-88372 26984931 34 12646
2026-05-14 S-3 REGISTRATION STATEMENT 0001213900-26-056057 333-295862 26975159 33 1065343 1 1
2026-05-13 10-Q QUARTERLY REPORT 0001213900-26-055463 001-36694 26971017 34 4855676 1 1
2026-05-13 8-K CURRENT REPORT 2.02,9.01 0001213900-26-055462 001-36694 26971004 34 281079 1 1
2026-04-28 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-048556 001-36694 26907980 34 2875993
2026-04-28 ARS ANNUAL REPORT 0001213900-26-048544 001-36694 26907812 34 670176
2026-04-28 DEF 14A PROXY STATEMENT 0001213900-26-048536 001-36694 26907597 34 11439069 1 1
2026-04-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-001712 005-88372 26901079 34 11007
2026-04-23 144 xsl144X01/primary_doc.xml 0001104659-26-047969 001-36694 26890176 33 7886
2026-04-23 144 xsl144X01/primary_doc.xml 0001104659-26-047967 001-36694 26890173 33 7689
2026-04-17 PRE 14A PROXY STATEMENT 0001213900-26-045170 001-36694 26871759 34 11440264 1 1
2026-04-09 4 PRIMARY DOCUMENT 0001213900-26-042079 5252
2026-04-02 4 PRIMARY DOCUMENT 0001213900-26-039328 5732
2026-04-01 144 xsl144X01/primary_doc.xml 0001949846-26-000197 001-36694 26825458 33 4566
2026-03-30 8-K CURRENT REPORT 7.01 0001213900-26-035971 001-36694 26810023 34 190284 1 1
2026-03-10 10-K ANNUAL REPORT 0001213900-26-025433 001-36694 26737291 34 8453552 1 1
2026-03-10 8-K CURRENT REPORT 2.02,9.01 0001213900-26-025432 001-36694 26737283 34 288312 1 1
2026-03-06 144 xsl144X01/primary_doc.xml 0001104659-26-024805 001-36694 26732523 33 7086
2026-03-06 144 xsl144X01/primary_doc.xml 0001104659-26-024803 001-36694 26732517 33 7256
2026-03-06 424B7 PROSPECTUS SUPPLEMENT 0001213900-26-024668 333-279067 26731171 33 25633
2026-03-04 144 xsl144X01/primary_doc.xml 0001104659-26-023665 001-36694 26723812 33 6487
2026-03-04 144 xsl144X01/primary_doc.xml 0001104659-26-023663 001-36694 26723807 33 6630
2026-03-02 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-022274 005-88372 26707942 34 15551
2026-02-25 144 xsl144X01/primary_doc.xml 0001104659-26-019854 001-36694 26681098 33 6478
2026-02-25 144 xsl144X01/primary_doc.xml 0001104659-26-019853 001-36694 26681094 33 6667
2026-02-24 144 xsl144X01/primary_doc.xml 0001104659-26-019328 001-36694 26673957 33 5306
2026-02-24 144 xsl144X01/primary_doc.xml 0001104659-26-019326 001-36694 26673945 33 5432
2026-02-24 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-26-019617 001-36694 26667692 34 29386765 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-26-000085 005-88372 26642375 34 12565
2026-02-02 424B7 PROSPECTUS SUPPLEMENT 0001213900-26-010806 333-279067 26588310 33 31051
2026-01-27 4 PRIMARY DOCUMENT 0001213900-26-008222 5111
2026-01-27 4 PRIMARY DOCUMENT 0001213900-26-008221 5088
2026-01-27 4 PRIMARY DOCUMENT 0001213900-26-008224 5148
2026-01-27 4 PRIMARY DOCUMENT 0001213900-26-008223 5160
2026-01-22 4 PRIMARY DOCUMENT 0001213900-26-006711 5169
2026-01-22 4 PRIMARY DOCUMENT 0001213900-26-006709 5088
2026-01-22 4 PRIMARY DOCUMENT 0001213900-26-006708 5180
2026-01-22 4 PRIMARY DOCUMENT 0001213900-26-006707 5131
2026-01-21 4 PRIMARY DOCUMENT 0001213900-26-006231 7753
2026-01-21 4 PRIMARY DOCUMENT 0001213900-26-006230 7694
2026-01-21 4 PRIMARY DOCUMENT 0001213900-26-006229 7713
2026-01-21 4 PRIMARY DOCUMENT 0001213900-26-006228 7765
2026-01-21 4 PRIMARY DOCUMENT 0001213900-26-006226 7754
2026-01-21 4 PRIMARY DOCUMENT 0001213900-26-006225 7766
2026-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000705 005-88372 26545895 34 10970
2025-12-15 8-K CURRENT REPORT 8.01,9.01 0001213900-25-121687 001-36694 251571772 34 219483 1 1
2025-12-09 424B7 PROSPECTUS SUPPLEMENT 0001213900-25-119667 333-279067 251559256 33 41424
2025-12-08 8-K CURRENT REPORT 1.01,9.01 0001213900-25-119242 001-36694 251556281 34 559580 1 1
2025-12-05 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-118744 333-275290 251553360 33 679429
2025-12-04 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-118304 333-275290 251549671 33 715240
2025-12-03 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-25-117577 001-36694 251545039 34 8392007 1 1
2025-11-19 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-25-112383 001-36694 251496855 34 17340384 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000287 005-88372 251483179 34 10898
2025-11-10 10-Q QUARTERLY REPORT 0001213900-25-107881 001-36694 251464470 34 5079389 1 1
2025-11-10 8-K CURRENT REPORT 2.02,9.01 0001213900-25-107873 001-36694 251464448 34 283654 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-022020 005-88372 251221511 34 16048
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000217 005-88372 251215749 34 10898
2025-08-11 S-8 REGISTRATION STATEMENT 0001213900-25-074386 333-289494 251202943 33 220489 1 1
2025-08-11 10-Q QUARTERLY REPORT 0001213900-25-073942 001-36694 251200281 34 5792155 1 1
2025-08-11 8-K CURRENT REPORT 2.02,9.01 0001213900-25-073937 001-36694 251200269 34 275701 1 1
2025-07-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003111 005-88372 251132270 34 10919
2025-07-07 4 PRIMARY DOCUMENT 0001213900-25-061772 6086
2025-06-30 4 PRIMARY DOCUMENT 0001213900-25-059655 9302
2025-06-13 4 PRIMARY DOCUMENT 0001213900-25-054286 5701
2025-06-13 4 PRIMARY DOCUMENT 0001213900-25-054285 5824
2025-06-13 4 PRIMARY DOCUMENT 0001213900-25-054288 5864
2025-06-13 4 PRIMARY DOCUMENT 0001213900-25-054284 5860
2025-06-13 4 PRIMARY DOCUMENT 0001213900-25-054287 5806
2025-06-13 4 PRIMARY DOCUMENT 0001213900-25-054283 5795
2025-06-13 4 PRIMARY DOCUMENT 0001213900-25-054282 5817
2025-06-13 4 PRIMARY DOCUMENT 0001213900-25-054280 5818
2025-06-12 8-K CURRENT REPORT 5.07 0001213900-25-053844 001-36694 251042707 34 202046 1 1
2025-06-04 4 xslF345X05/ownership.xml 0001213900-25-051157 7599
2025-06-04 3 xslF345X02/ownership.xml 0001213900-25-051149 8691
2025-05-19 4/A PRIMARY DOCUMENT 0001213900-25-045399 5567
2025-05-16 4 PRIMARY DOCUMENT 0001213900-25-044871 5319
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000136 005-88372 25943862 34 10831
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002235 005-88372 25932844 34 12027
2025-05-08 10-Q QUARTERLY REPORT 0001213900-25-040811 001-36694 25924004 34 4812188 1 1
2025-05-08 8-K CURRENT REPORT 2.02,9.01 0001213900-25-040809 001-36694 25923982 34 287064 1 1
2025-04-28 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-006421 005-88372 25880222 34 6790
2025-04-28 424B7 PROSPECTUS SUPPLEMENT 0001213900-25-035797 333-279067 25876258 33 23281
2025-04-28 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-25-035785 001-36694 25876211 34 15388919 1 1
2025-04-25 DEFA14A ADDITIONAL MATERIALS 0001213900-25-035585 001-36694 25874381 34 2648209
2025-04-25 ARS ANNUAL REPORT 0001213900-25-035579 001-36694 25874239 34 653021
2025-04-25 DEF 14A PROXY STATEMENT 0001213900-25-035568 001-36694 25874122 34 9974122 1 1
2025-04-17 4 xslF345X05/ownership.xml 0001213900-25-032965 7642
2025-04-17 3 xslF345X02/ownership.xml 0001213900-25-032954 9348
2025-03-28 4 PRIMARY DOCUMENT 0001013762-25-004101 5593
2025-03-28 4/A PRIMARY DOCUMENT 0001013762-25-004078 4281
2025-03-28 4/A PRIMARY DOCUMENT 0001013762-25-004077 4329
2025-03-28 4/A PRIMARY DOCUMENT 0001013762-25-004075 4285
2025-03-28 4/A PRIMARY DOCUMENT 0001013762-25-004074 4343
2025-03-26 144 xsl144X01/primary_doc.xml 0001949846-25-000149 001-36694 25770810 33 4552
2025-03-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000104 005-88372 25718777 34 10911
2025-03-05 S-8 REGISTRATION STATEMENT 0001213900-25-020723 333-285568 25711244 33 74946
2025-03-05 10-K ANNUAL REPORT 0001213900-25-020368 001-36694 25708938 34 7745507 1 1
2025-03-05 8-K CURRENT REPORT 2.02,9.01 0001213900-25-020366 001-36694 25708911 34 286206 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004295 005-88372 25631794 34 20655
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-014361 005-88372 25631662 34 19100
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-001020 005-88372 25628403 34 9290
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000036 005-88372 25625067 34 10788
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-006563 005-88372 25623039 34 6991
2025-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-000856 005-88372 25612561 34 16016
2025-01-28 4 PRIMARY DOCUMENT 0001213900-25-007533 7658
2025-01-28 4 PRIMARY DOCUMENT 0001213900-25-007532 7672
2025-01-28 4 PRIMARY DOCUMENT 0001213900-25-007531 7610
2025-01-28 4 PRIMARY DOCUMENT 0001213900-25-007530 7610
2025-01-23 4 PRIMARY DOCUMENT 0001213900-25-005962 5164
2025-01-23 4 PRIMARY DOCUMENT 0001213900-25-005966 5095
2025-01-23 4 PRIMARY DOCUMENT 0001213900-25-005964 5119
2025-01-23 4 PRIMARY DOCUMENT 0001213900-25-005963 5176
2025-01-13 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-25-003026 001-36694 25526743 34 25007865 1 1
2025-01-07 4 PRIMARY DOCUMENT 0001213900-25-001648 5142
2025-01-07 4 PRIMARY DOCUMENT 0001213900-25-001646 5156
2025-01-07 4 PRIMARY DOCUMENT 0001213900-25-001645 5097
2024-12-17 SC 13G THE SCHEDULE 13G 0000921895-24-002967 005-88372 241555594 34 251365
2024-12-11 8-K CURRENT REPORT 1.01,7.01,9.01 0001213900-24-107906 001-36694 241541766 34 700416 1 1
2024-12-11 424B5 PROSPECTUS SUPPLEMENT 0001213900-24-107640 333-275290 241540141 33 498091
2024-12-09 424B5 PROSPECTUS SUPPLEMENT 0001213900-24-106942 333-275290 241535332 33 498576
2024-12-05 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-24-105782 001-36694 241527947 34 10603391 1 1
2024-11-18 SC 13G formsc13g.htm 0001493152-24-046391 005-88372 241469637 34 79246
2024-11-14 SC 13G PROTARA THERAPEUTICS, INC. 0000902664-24-006573 005-88372 241459661 34 50961
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-118633 005-88372 241459293 34 60299
2024-11-12 10-Q QUARTERLY REPORT 0001213900-24-096252 001-36694 241443609 34 4751493 1 1
2024-11-12 8-K CURRENT REPORT 2.02,9.01 0001213900-24-096243 001-36694 241443547 34 282740 1 1
2024-09-12 4 xslF345X05/ownership.xml 0001493152-24-036106 11674
2024-09-10 4 xslF345X05/ownership.xml 0001493152-24-035684 11673
2024-08-30 4 PRIMARY DOCUMENT 0001213900-24-074514 6348
2024-08-06 S-8 REGISTRATION STATEMENT 0001213900-24-065668 333-281286 241179483 33 83432
2024-08-06 10-Q QUARTERLY REPORT 0001213900-24-065380 001-36694 241177190 34 5126823 1 1
2024-08-06 8-K CURRENT REPORT 2.02,9.01 0001213900-24-065378 001-36694 241177180 34 295714 1 1
2024-07-18 4 xslF345X05/ownership.xml 0001493152-24-028330 7855
2024-07-11 4 xslF345X05/ownership.xml 0001493152-24-027028 15499
2024-07-03 4 xslF345X05/ownership.xml 0001493152-24-026181 7854
2024-06-28 4 xslF345X05/ownership.xml 0001493152-24-025666 11673
2024-06-27 4 xslF345X05/ownership.xml 0001493152-24-025428 7856
2024-06-10 4 PRIMARY DOCUMENT 0001213900-24-051382 5892
2024-06-10 4 PRIMARY DOCUMENT 0001213900-24-051381 5881
2024-06-10 4 PRIMARY DOCUMENT 0001213900-24-051380 5939
2024-06-10 4 PRIMARY DOCUMENT 0001213900-24-051379 5776
2024-06-10 4 PRIMARY DOCUMENT 0001213900-24-051378 5899
2024-06-10 4 PRIMARY DOCUMENT 0001213900-24-051377 5935
2024-06-10 4 PRIMARY DOCUMENT 0001213900-24-051376 5870
2024-06-10 4 PRIMARY DOCUMENT 0001213900-24-051375 5893
2024-06-10 8-K CURRENT REPORT 5.07 0001213900-24-051210 001-36694 241032644 34 213804 1 1
2024-05-31 4 xslF345X05/ownership.xml 0001493152-24-022195 8004
2024-05-23 4 xslF345X05/ownership.xml 0001493152-24-021230 11693
2024-05-17 4 xslF345X05/ownership.xml 0001493152-24-020507 11693
2024-05-10 4 xslF345X05/ownership.xml 0001493152-24-018723 7989
2024-05-09 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-05-09 16:00:00 9999999995-24-001461 333-279067 24932684 33 1961
2024-05-09 424B3 PROSPECTUS 0001213900-24-041339 333-279067 24931278 33 262191
2024-05-07 CORRESP filename1.htm 0001213900-24-040390 13904
2024-05-07 UPLOAD filename1.pdf 0000000000-24-005170 333-279067 40434
2024-05-02 S-3 REGISTRATION STATEMENT 0001213900-24-039126 333-279067 24908512 33 421464
2024-05-02 10-Q QUARTERLY REPORT 0001213900-24-038757 001-36694 24905447 34 4333300 1 1
2024-05-02 8-K CURRENT REPORT 2.02,9.01 0001213900-24-038756 001-36694 24905418 34 314209 1 1
2024-04-26 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-24-036639 001-36694 24883730 34 3856181
2024-04-26 ARS ANNUAL REPORT 0001213900-24-036636 001-36694 24883690 34 577367
2024-04-26 DEF 14A PROXY STATEMENT 0001213900-24-036627 001-36694 24883586 34 5838651
2024-04-25 SC 13G SC 13G 0001104659-24-052181 005-88372 24878294 34 94291
2024-04-22 SC 13G SC 13G 0001104659-24-049972 005-88372 24861217 34 130709
2024-04-09 SC 13G SC 13G 0001104659-24-045067 005-88372 24831540 34 68454
2024-04-05 8-K CURRENT REPORT 1.01,3.02,7.01,8.01,9.01 0001213900-24-030623 001-36694 24824807 34 19134798 1 1
2024-03-18 8-K CURRENT REPORT 5.02,9.01 0001213900-24-023589 001-36694 24760090 34 282888 1 1
2024-03-14 S-8 REGISTRATION STATEMENT 0001213900-24-022607 333-277931 24750157 33 94672
2024-03-13 10-K ANNUAL REPORT 0001213900-24-021982 001-36694 24744639 34 7502913 1 1
2024-03-13 8-K CURRENT REPORT 2.02,9.01 0001213900-24-021981 001-36694 24744631 34 291948 1 1
2024-02-14 SC 13G/A AMENDMENT NO. 2 0000947871-24-000157 005-88372 24641424 34 59770
2024-01-23 4 PRIMARY DOCUMENT 0001213900-24-005725 9415
2024-01-23 4 PRIMARY DOCUMENT 0001213900-24-005726 9438
2024-01-23 4 PRIMARY DOCUMENT 0001213900-24-005724 9429
2024-01-23 4 PRIMARY DOCUMENT 0001213900-24-005723 7616
2024-01-23 4 PRIMARY DOCUMENT 0001213900-24-005722 9365
2024-01-12 4 PRIMARY DOCUMENT 0001213900-24-003336 5143
2024-01-12 4 PRIMARY DOCUMENT 0001213900-24-003335 5156
2024-01-12 4 PRIMARY DOCUMENT 0001213900-24-003334 5167
2024-01-05 4 PRIMARY DOCUMENT 0001213900-24-001546 5170
2024-01-05 4 PRIMARY DOCUMENT 0001213900-24-001541 5157
2024-01-05 4 PRIMARY DOCUMENT 0001213900-24-001512 5118
2023-11-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-11-14 16:00:00 9999999995-23-003325 333-275290 231408936 33 1913
2023-11-09 CORRESP filename1.htm 0001213900-23-085377 8054
2023-11-07 UPLOAD filename1.pdf 0000000000-23-012183 40457
2023-11-03 S-3 REGISTRATION STATEMENT 0001213900-23-083014 333-275290 231374579 33 451082
2023-11-03 10-Q QUARTERLY REPORT 0001213900-23-083013 001-36694 231374557 34 4252980 1 1
2023-11-03 8-K CURRENT REPORT 2.02,9.01 0001213900-23-083011 001-36694 231374544 34 301201 1 1
2023-08-03 10-Q QUARTERLY REPORT 0001213900-23-062782 001-36694 231138218 34 4208022 1 1
2023-08-03 8-K CURRENT REPORT 2.02,9.01 0001213900-23-062780 001-36694 231138206 34 291511 1 1
2023-07-18 4 PRIMARY DOCUMENT 0001213900-23-057844 5037
2023-07-05 4 PRIMARY DOCUMENT 0001213900-23-054759 5081
2023-06-27 4 xslF345X04/ownership.xml 0001213900-23-052231 6171
2023-06-08 4 xslF345X04/ownership.xml 0001213900-23-047471 13373
2023-06-08 4 xslF345X04/ownership.xml 0001213900-23-047470 11555
2023-06-08 4 xslF345X04/ownership.xml 0001213900-23-047472 11607
2023-06-08 4 xslF345X04/ownership.xml 0001213900-23-047469 13166
2023-06-08 4 xslF345X04/ownership.xml 0001213900-23-047467 13264
2023-06-08 4 xslF345X04/ownership.xml 0001213900-23-047468 11806
2023-06-08 4 xslF345X04/ownership.xml 0001213900-23-047466 11739
2023-06-08 4 xslF345X04/ownership.xml 0001213900-23-047465 11562
2023-06-08 8-K CURRENT REPORT 5.07 0001213900-23-047460 001-36694 231001937 34 206707 1 1
2023-05-04 10-Q QUARTERLY REPORT 0001213900-23-036113 001-36694 23886647 34 4158385 1 1
2023-05-04 8-K CURRENT REPORT 2.02,9.01 0001213900-23-036112 001-36694 23886615 34 270297 1 1
2023-05-02 8-K CURRENT REPORT 7.01,9.01 0001213900-23-035154 001-36694 23876683 34 229197 1 1
2023-04-28 8-K CURRENT REPORT 7.01,9.01 0001213900-23-033507 001-36694 23860352 34 228151 1 1
2023-04-26 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-23-032829 001-36694 23849854 34 755325
2023-04-26 ARS ANNUAL REPORT 0001213900-23-032827 001-36694 23849791 34 669522
2023-04-26 DEF 14A PROXY STATEMENT 0001213900-23-032824 001-36694 23849689 34 5450013
2023-03-10 8-K CURRENT REPORT 7.01 0001213900-23-019281 001-36694 23724908 34 201357 1 1
2023-03-08 S-8 REGISTRATION STATEMENT 0001213900-23-018541 333-270354 23716238 33 149155
2023-03-08 10-K ANNUAL REPORT 0001213900-23-018373 001-36694 23714911 34 6959365 1 1
2023-03-08 8-K CURRENT REPORT 2.02,9.01 0001213900-23-018371 001-36694 23714909 34 321416 1 1
2023-02-14 SC 13G/A AMENDMENT NO. 1 0000947871-23-000184 005-88372 23630937 34 60682
2023-02-10 5 xslF345X03/ownership.xml 0001213900-23-010283 4790
2023-01-30 4 xslF345X03/ownership.xml 0001213900-23-006044 5690
2023-01-30 3 xslF345X02/ownership.xml 0001213900-23-006043 9624
2023-01-30 8-K CURRENT REPORT 5.02,7.01,9.01 0001213900-23-005811 001-36694 23565303 34 227716 1 1
2023-01-20 4 xslF345X03/ownership.xml 0001213900-23-004081 7534
2023-01-20 4 xslF345X03/ownership.xml 0001213900-23-004080 7491
2023-01-20 4 xslF345X03/ownership.xml 0001213900-23-004082 7546
2023-01-20 4 xslF345X03/ownership.xml 0001213900-23-004079 7542
2023-01-11 4 xslF345X03/ownership.xml 0001213900-23-002266 4988
2023-01-11 4 xslF345X03/ownership.xml 0001213900-23-002261 4976
2023-01-11 4 xslF345X03/ownership.xml 0001213900-23-002260 4984
2023-01-05 8-K CURRENT REPORT 8.01,9.01 0001213900-23-001140 001-36694 23512092 34 4735718 1 1
2023-01-04 4 xslF345X03/ownership.xml 0001213900-23-000857 10270
2023-01-04 4 xslF345X03/ownership.xml 0001213900-23-000854 10527
2023-01-04 4 xslF345X03/ownership.xml 0001213900-23-000853 4935
2022-12-30 4 xslF345X03/ownership.xml 0001493152-22-037191 7723
2022-11-03 10-Q QUARTERLY REPORT 0001213900-22-069010 001-36694 221358558 34 4057939 1 1
2022-11-03 8-K CURRENT REPORT 2.02,9.01 0001213900-22-068819 001-36694 221356365 34 276662 1 1
2022-09-15 4 xslF345X03/ownership.xml 0001493152-22-025978 10620
2022-08-15 4 xslF345X03/ownership.xml 0001213900-22-048179 5122
2022-08-09 10-Q QUARTERLY REPORT 0001213900-22-045922 001-36694 221148855 34 4203182 1 1
2022-08-09 8-K CURRENT REPORT 2.02,9.01 0001213900-22-045601 001-36694 221146512 34 295025 1 1
2022-07-19 4 OWENER SHIP DOCUMENT 0001213900-22-040317 5011
2022-07-19 4 xslF345X03/ownership.xml 0001213900-22-040288 5021
2022-07-19 3 xslF345X02/ownership.xml 0001213900-22-040285 17423
2022-07-18 8-K CURRENT REPORT 5.02 0001213900-22-039976 001-36694 221089250 34 220268 1 1
2022-07-05 4 xslF345X03/ownership.xml 0001213900-22-037267 4980
2022-07-05 4 xslF345X03/ownership.xml 0001213900-22-037266 4629
2022-06-21 8-K CURRENT REPORT 5.02,7.01,9.01 0001213900-22-033756 001-36694 221026135 34 292605 1 1
2022-06-09 4 xslF345X03/ownership.xml 0001213900-22-031990 5698
2022-06-09 4 xslF345X03/ownership.xml 0001213900-22-031996 5752
2022-06-09 4 xslF345X03/ownership.xml 0001213900-22-031992 5593
2022-06-09 4 xslF345X03/ownership.xml 0001213900-22-031994 5716
2022-06-09 4 xslF345X03/ownership.xml 0001213900-22-031991 5687
2022-06-09 4 xslF345X03/ownership.xml 0001213900-22-031995 5709
2022-06-09 4 xslF345X03/ownership.xml 0001213900-22-031993 5756
2022-06-09 4 xslF345X03/ownership.xml 0001213900-22-031989 5710
2022-06-09 8-K CURRENT REPORT 5.07 0001213900-22-031985 001-36694 221005991 34 203864 1 1
2022-05-05 10-Q QUARTERLY REPORT 0001213900-22-024238 001-36694 22896914 34 3926206 1 1
2022-05-05 8-K CURRENT REPORT 2.02,9.01 0001213900-22-024098 001-36694 22894194 34 286482 1 1
2022-04-27 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-22-021915 001-36694 22859661 34 595604
2022-04-27 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-22-021905 001-36694 22859514 34 4699784
2022-04-15 4/A xslF345X03/ownership.xml 0001493152-22-010003 11835
2022-04-08 4 xslF345X03/ownership.xml 0001493152-22-009511 11759
2022-03-16 4 FORM 4 SUBMISSION 0001209191-22-019238 4674
2022-03-14 4 FORM 4 SUBMISSION 0001209191-22-018478 5109
2022-03-09 4/A FORM 4/A SUBMISSION 0001209191-22-017592 4298
2022-03-09 S-8 REGISTRATION STATEMENT 0001213900-22-011313 333-263392 22725501 33 112872
2022-03-09 10-K ANNUAL REPORT 0001213900-22-011208 001-36694 22723979 34 6643969 1 1
2022-03-09 8-K FORM 8-K 2.02,9.01 0001213900-22-011205 001-36694 22723934 34 277781 1 1
2022-02-15 SC 13G/A SC 13G/A 0001193125-22-042466 005-88372 22636156 34 64338
2022-02-15 SC 13G/A rocksprings-tara123121a2.htm 0001172661-22-000971 005-88372 22635888 34 109838
2022-02-14 SC 13G/A SC 13G/A 0001193125-22-041948 005-88372 22633362 34 84715
2022-02-11 5 FORM 5 SUBMISSION 0001209191-22-008912 6387
2022-02-11 SC 13G SCHEDULE 13G 0000947871-22-000210 005-88372 22621871 34 62041
2022-01-31 4 xslF345X03/ownership.xml 0001493152-22-002708 7838
2022-01-12 4 FORM 4 SUBMISSION 0001209191-22-003091 5051
2022-01-12 4 FORM 4 SUBMISSION 0001209191-22-003088 5021
2022-01-12 4 FORM 4 SUBMISSION 0001209191-22-003084 7645
2022-01-12 3 FORM 3 SUBMISSION 0001209191-22-003078 16596
2022-01-10 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-22-001222 001-36694 22519815 34 223678 1 1
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001725 7650
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001719 7637
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001715 7636
2021-12-29 4 xslF345X03/ownership.xml 0001493152-21-032722 10041
2021-12-27 4 xslF345X03/ownership.xml 0001493152-21-032554 11753
2021-12-22 4 xslF345X03/ownership.xml 0001493152-21-032275 5636
2021-12-20 4 xslF345X03/ownership.xml 0001493152-21-032025 11745
2021-11-19 4 xslF345X03/ownership.xml 0001493152-21-029376 11757
2021-11-08 4 xslF345X03/ownership.xml 0001493152-21-027485 7267
2021-11-04 10-Q QUARTERLY REPORT 0001213900-21-056770 001-36694 211380576 34 4464185 1 1
2021-11-04 8-K CURRENT REPORT 2.02,9.01 0001213900-21-056585 001-36694 211378121 34 401119 1 1
2021-10-18 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-21-053303 001-36694 211328793 34 368538 1 1
2021-10-12 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-21-052250 001-36694 211316891 34 5473192 1 1
2021-08-05 10-Q QUARTERLY REPORT 0001213900-21-040535 001-36694 211148834 34 4584014 1 1
2021-08-05 8-K CURRENT REPORT 2.02,9.01 0001213900-21-040412 001-36694 211146404 34 295004 1 1
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040311 6314
2021-06-10 4 FORM 4 SUBMISSION 0001209191-21-039727 8260
2021-06-10 3 FORM 3 SUBMISSION 0001209191-21-039725 6147
2021-06-10 4 FORM 4 SUBMISSION 0001209191-21-039691 5727
2021-06-10 4 FORM 4 SUBMISSION 0001209191-21-039688 5716
2021-06-10 4 FORM 4 SUBMISSION 0001209191-21-039687 5734
2021-06-10 4 FORM 4 SUBMISSION 0001209191-21-039686 5774
2021-06-10 4 FORM 4 SUBMISSION 0001209191-21-039685 5611
2021-06-10 4 FORM 4 SUBMISSION 0001209191-21-039683 5705
2021-06-10 4 FORM 4 SUBMISSION 0001209191-21-039680 5728
2021-06-10 3/A FORM 3/A SUBMISSION 0001209191-21-039623 6284
2021-06-10 8-K CURRENT REPORT 5.02,5.07,7.01,9.01 0001213900-21-031798 001-36694 211006949 34 56035
2021-05-06 10-Q QUARTERLY REPORT 0001213900-21-024773 001-36694 21895760 34 3126327 1
2021-04-27 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-21-023069 001-36694 21858983 34 598236
2021-04-27 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-21-023066 001-36694 21858900 34 3803987
2021-04-23 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-21-022652 001-36694 21846665 34 6289973
2021-04-20 4 FORM 4 SUBMISSION 0001209191-21-027691 5805
2021-04-20 3 FORM 3 SUBMISSION 0001209191-21-027690 6853
2021-04-19 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-21-022105 001-36694 21834966 34 45968
2021-03-23 SEC STAFF LETTER filename1.pdf 9999999997-21-000955 276243
2021-03-17 8-K CURRENT REPORT 4.01,9.01 0001213900-21-016115 001-36694 21751507 34 37070
2021-03-11 S-8 REGISTRATION STATEMENT 0001213900-21-014711 333-254124 21731866 33 86351
2021-03-11 10-K ANNUAL REPORT 0001213900-21-014709 001-36694 21731813 34 5439539 1
2021-03-03 8-K CURRENT REPORT 8.01,9.01 0001213900-21-013062 001-36694 21707265 34 6577638
2021-02-23 SEC STAFF LETTER filename1.pdf 9999999997-21-000603 277162
2021-02-16 SC 13G/A rocksprings-tara123120a1.htm 0001172661-21-000758 005-88372 21639339 34 109991
2021-02-16 SC 13G/A SC 13G/A 0001193125-21-044733 005-88372 21637290 34 66705
2021-02-12 SC 13G/A SC 13G/A 0001193125-21-041665 005-88372 21628180 34 109301
2021-02-11 8-K CURRENT REPORT 8.01,9.01 0001213900-21-008283 001-36694 21616801 34 9085581
2021-02-02 8-K CURRENT REPORT 5.02,7.01,9.01 0001213900-21-005977 001-36694 21579093 34 47078
2021-02-01 4 FORM 4 SUBMISSION 0001209191-21-006571 8203
2021-02-01 3 FORM 3 SUBMISSION 0001209191-21-006570 6103
2021-01-21 4 FORM 4 SUBMISSION 0001209191-21-004653 5681
2021-01-21 4 FORM 4 SUBMISSION 0001209191-21-004652 5695
2021-01-21 4 FORM 4 SUBMISSION 0001209191-21-004651 5667
2021-01-13 4 FORM 4 SUBMISSION 0001209191-21-003448 5006
2021-01-13 4 FORM 4 SUBMISSION 0001209191-21-003445 4977
2021-01-08 SC 13D/A e620199_sc13da-pt.htm 0001193805-21-000026 005-88372 21517322 34 161915
2020-12-18 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-12-18 16:30:00 9999999995-20-003587 333-251224 201402282 33 1875
2020-12-16 UPLOAD filename1.pdf 0000000000-20-012065 40367
2020-12-15 CORRESP filename1.htm 0001213900-20-042845 8332
2020-12-09 S-3 REGISTRATION STATEMENT 0001213900-20-041803 333-251224 201378005 33 576414
2020-12-08 8-K CURRENT REPORT 1.01 0001213900-20-041613 001-36694 201375813 34 18797
2020-12-07 8-K CURRENT REPORT 5.02 0001213900-20-041347 001-36694 201373053 34 19189
2020-11-17 8-K CURRENT REPORT 8.01,9.01 0001213900-20-037553 001-36694 201319356 34 6706823
2020-11-12 10-Q QUARTERLY REPORT 0001213900-20-036343 001-36694 201303270 34 3840157 1
2020-10-08 8-K/A AMENDMENT NO. 1 TO FORM 8-K 5.07 0001213900-20-030629 001-36694 201231055 34 27118
2020-10-02 SC 13G rocksprings-tara092220.htm 0001172661-20-001896 005-88372 201219768 34 110232
2020-10-02 4 xslF345X03/ownership.xml 0001493152-20-018753 6322
2020-10-01 SC 13G SC 13G 0001193125-20-261302 005-88372 201215969 34 65123
2020-09-25 SC 13D/A sc13da.htm 0001493152-20-018377 005-88372 201201031 34 153937
2020-09-25 4 xslF345X03/ownership.xml 0001493152-20-018373 7248
2020-09-23 4 FORM 4 SUBMISSION 0001209191-20-051631 5135
2020-09-23 8-K CURRENT REPORT 1.01,5.03,8.01,9.01 0001213900-20-027951 001-36694 201191059 34 618279
2020-09-23 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-027949 333-238273 201191055 33 595432
2020-09-23 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-027946 333-238273 201191052 33 607074
2020-09-22 S-3MEF REGISTRATION STATEMENT 0001213900-20-027736 333-248964 201187987 33 53935
2020-09-21 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-027556 333-238273 201186542 33 608098
2020-09-21 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-027553 333-238273 201186531 33 614962
2020-09-15 4 FORM 4 - 0001179110-20-009785 6748
2020-09-14 4 FORM 4 - 0001179110-20-009717 4548
2020-09-10 4 FORM 4 - 0001179110-20-009662 8345
2020-09-08 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-20-025513 001-36694 201162943 34 8243721
2020-09-04 4 FORM 4 - 0001179110-20-009590 6733
2020-09-01 4 FORM 4 - 0001179110-20-009466 5124
2020-08-28 4 FORM 4 - 0001179110-20-009407 6736
2020-08-26 4 FORM 4 - 0001179110-20-009359 6735
2020-08-24 4 FORM 4 - 0001179110-20-009241 5126
2020-08-20 4 FORM 4 - 0001179110-20-009191 5124
2020-08-18 4 FORM 4 - 0001179110-20-009153 6735
2020-07-31 4 FORM 4 - 0001179110-20-008623 9707
2020-07-31 10-Q QUARTERLY REPORT 0001213900-20-019642 001-36694 201066217 34 3666562 1
2020-07-29 4 FORM 4 - 0001179110-20-008539 16352
2020-07-27 4 FORM 4 SUBMISSION 0001209191-20-043742 8170
2020-07-27 3 FORM 3 SUBMISSION 0001209191-20-043739 3040
2020-07-27 4 FORM 4 - 0001179110-20-008490 8097
2020-07-24 8-K CURRENT REPORT 5.02,7.01,9.01 0001213900-20-018461 001-36694 201045051 34 42167
2020-07-23 4 FORM 4 - 0001179110-20-008426 8099
2020-07-21 4 FORM 4 - 0001179110-20-008399 8344
2020-07-16 8-K CURRENT REPORT 1.01 0001213900-20-017650 001-36694 201031605 34 31704
2020-07-14 4 FORM 4 - 0001179110-20-008254 9645
2020-07-13 4 FORM 4 SUBMISSION 0001209191-20-042242 5633
2020-06-11 4 FORM 4 SUBMISSION 0001209191-20-035852 5686
2020-06-11 4 FORM 4 SUBMISSION 0001209191-20-035851 5563
2020-06-11 4 FORM 4 SUBMISSION 0001209191-20-035850 5726
2020-06-11 4/A FORM 4/A SUBMISSION 0001209191-20-035849 12286
2020-06-11 4 FORM 4 SUBMISSION 0001209191-20-035848 5657

Latest XBRL company facts

One latest value per concept from companyfacts (427 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 61.57M 2026-11-03 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
dei EntityNumberOfEmployees Entity Number of Employees pure 1 2019-09-30 2019 Q3 10-Q 2019-10-31 0001171843-19-007045
dei EntityPublicFloat Entity Public Float USD 112.30M 2025-06-30 2025 FY 10-K 2026-03-10 0001213900-26-025433
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.41M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001213900-26-048536
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.38M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001213900-26-048536
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 2.31M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001213900-26-048536
ecd PeoTotalCompAmt PeoTotalCompAmt USD 2.66M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001213900-26-048536
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 198.88 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001213900-26-048536
ffd NetFeeAmt NetFeeAmt USD 3,247.77 2026-07-28 S-8 2026-08-11 0001213900-26-087781
ffd TtlFeeAmt TtlFeeAmt USD 3,247.77 2026-07-28 S-8 2026-08-11 0001213900-26-087781
ffd TtlOfferingAmt TtlOfferingAmt USD 23.52M 2026-07-28 S-8 2026-08-11 0001213900-26-087781
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-28 S-8 2026-08-11 0001213900-26-087781
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-05-11 S-3 2026-05-14 0001213900-26-056057
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 4.86M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 4,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap AccruedBonusesCurrentAndNoncurrent Accrued Bonuses USD 715,500 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036343
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 1.00M 2021-06-30 2021 Q2 10-Q 2021-08-05 0001213900-21-040535
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 8.22M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 21,000 2022-06-30 2022 Q2 10-Q 2022-08-09 0001213900-22-045922
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 27,000 2022-09-30 2022 Q3 10-Q 2022-11-03 0001213900-22-069010
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.47M 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -550,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 505.07M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 6.36M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001213900-21-014709
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions APIC, Share-based Payment Arrangement, Recognition and Exercise USD 108,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-13 0001171843-19-001687
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 314,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-04 0001213900-23-036113
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 367,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 1.22M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 3.22M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001213900-24-096252
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD -331,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-03 0001213900-23-083013
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 8.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap AreaOfLand Area of Land sqft 10,300 2023-12-31 2023 FY 10-K 2024-03-13 0001213900-24-021982
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 7,495 2019-06-30 2019 Q2 10-Q 2019-08-07 0001171843-19-005225
us-gaap Assets Assets USD 156.54M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap AssetsCurrent Assets, Current USD 129.67M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 198.04M 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 2.52M 2022-12-31 2023 Q2 10-Q 2023-08-03 0001213900-23-062782
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 26.02M 2023-12-31 2024 Q2 10-Q 2024-08-06 0001213900-24-065380
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 550,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 96.97M 2021-03-31 2021 Q1 10-Q 2021-05-06 0001213900-21-024773
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 1,000 2016-12-31 2017 FY 10-K 2018-03-14 0001171843-18-001934
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 164,000 2021-03-31 2021 Q1 10-Q 2021-05-06 0001213900-21-024773
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 2.50M 2018-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-13 0001171843-19-001687
us-gaap AvailableForSaleSecuritiesGrossUnrealizedGains Available-for-sale Securities, Gross Unrealized Gain USD 9,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-13 0001171843-15-004685
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLoss Available-for-sale Securities, Gross Unrealized Loss USD -2,000 2014-01-01 2014-12-31 2015 Q3 10-Q 2015-11-12 0001171843-15-006275
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -33.75M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 3.67M 2020-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets USD 1.66M 2020-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue USD 365,000 2020-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets USD 29.52M 2020-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap Cash Cash USD 745,000 2020-12-31 2021 Q3 10-Q 2021-11-04 0001213900-21-056770
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 25.15M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 26.32M 2021-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -15.22M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-14 0001171843-18-001934
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 6.20M 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 25.89M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 6.23M 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -24.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -13.16M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap CashCollateralForBorrowedSecurities Cash Collateral for Borrowed Securities USD 795,000 2020-12-31 2020 FY 10-K 2021-03-11 0001213900-21-014709
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 25.15M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap CashReserveDepositRequiredAndMade Cash Reserve Deposit Required and Made USD 50,000 2020-03-31 2020 Q1 10-Q 2020-05-13 0001213900-20-011893
us-gaap CertificatesOfDepositAtCarryingValue Certificates of Deposit, at Carrying Value USD 50,000 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 1.70M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001213900-24-096252
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 3.40M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 20,365 2021-09-30 2021 Q3 10-Q 2021-11-04 0001213900-21-056770
us-gaap CommonStockOtherSharesOutstanding Common Stock, Other Shares, Outstanding shares 2.63M 2021-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 59.97M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 59.97M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap CommonStockValue Common Stock, Value, Issued USD 60,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -61.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 8.65M 2014-10-27 2014 FY 10-K 2015-03-20 0001171843-15-001528
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 1,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-03 0001213900-23-062782
us-gaap ConvertibleDebt Convertible Debt USD 4.30M 2013-09-04 2015 Q2 10-Q 2015-08-13 0001171843-15-004685
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 3.73M 2013-12-31 2014 FY 10-K 2015-03-20 0001171843-15-001528
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 126.84M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001171843-17-001555
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 8.65M 2014-10-27 2014 FY 10-K 2015-03-20 0001171843-15-001528
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 6.09M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001171843-17-001555
us-gaap DebtCurrent Debt, Current USD 0 2021-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 7.00M 2013-09-04 2014 FY 10-K 2015-03-20 0001171843-15-001528
us-gaap DebtInstrumentConvertibleConversionRatio1 Debt Instrument, Convertible, Conversion Ratio pure 0.191 2020-01-03 2020-01-09 2020 FY 10-K 2021-03-11 0001213900-21-014709
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.08 2013-09-04 2015 Q2 10-Q 2015-08-13 0001171843-15-004685
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 1.40M 2013-09-04 2014 FY 10-K 2015-03-20 0001171843-15-001528
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 77,000 2023-09-30 2023 Q3 10-Q 2023-11-03 0001213900-23-083013
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 88,000 2023-09-30 2023 Q3 10-Q 2023-11-03 0001213900-23-083013
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD -39,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001213900-21-056770
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 116.97M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -13.65M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 100,000 2015-12-31 2015 FY 10-K 2016-03-14 0001171843-16-008541
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -11.04M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 934,000 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 385,000 2024-03-31 2024 Q1 10-Q 2024-05-02 0001213900-24-038757
us-gaap DeferredOtherTaxExpenseBenefit Deferred Other Tax Expense (Benefit) USD -8.65M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001213900-21-014709
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 2.95M 2013-12-31 2014 FY 10-K 2015-03-20 0001171843-15-001528
us-gaap DeferredRevenueRevenueRecognized Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) USD 2.90M 2014-08-03 2014 FY 10-K 2015-03-20 0001171843-15-001528
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 2.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 1.15M 2013-12-31 2015 FY 10-K 2016-03-14 0001171843-16-008541
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 74,000 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 84.48M 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 21.16M 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 267,000 2013-12-31 2014 FY 10-K 2015-03-20 0001171843-15-001528
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 934,000 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 44.91M 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 12.50M 2014-12-31 2014 FY 10-K 2015-03-20 0001171843-15-001528
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 842,000 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap DeferredTaxAssetsOtherLossCarryforwards Deferred Tax Assets, Other Loss Carryforwards USD 19.37M 2020-12-31 2020 FY 10-K 2021-03-11 0001213900-21-014709
us-gaap DeferredTaxAssetsOtherTaxCarryforwards Deferred Tax Assets, Other Tax Carryforwards USD 114.20M 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018373
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness Deferred Tax Assets, Tax Credit Carryforwards, General Business USD 3.59M 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 9.11M 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 443,000 2020-12-31 2020 FY 10-K 2021-03-11 0001213900-21-014709
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 6.34M 2024-12-31 2024 FY 10-K 2025-03-05 0001213900-25-020368
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 411,000 2018-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Returns and Allowances USD 72.51M 2024-12-31 2024 FY 10-K 2025-03-05 0001213900-25-020368
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 83.55M 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap DeferredTaxLiabilitiesCurrent Deferred Tax Liabilities, Net, Current USD 267,000 2013-12-31 2014 FY 10-K 2015-03-20 0001171843-15-001528
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 9.61M 2023-12-31 2023 FY 10-K 2024-03-13 0001213900-24-021982
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 96,000 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 78,000 2021-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap DeferredTaxLiabilitiesTaxDeferredIncome Deferred Tax Liabilities, Tax Deferred Income USD 322,000 2020-12-31 2020 FY 10-K 2021-03-11 0001213900-21-014709
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 342,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 237,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001213900-24-021982
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001213900-25-020368
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 39,000 2014-09-30 2014 Q3 10-Q 2014-11-25 0001171843-14-005683
us-gaap Depreciation Depreciation USD 233,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 115,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-07 0001171843-17-006678
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 1.44M 2013-12-31 2014 FY 10-K 2015-03-20 0001171843-15-001528
us-gaap DividendIncomeOperating Dividend Income, Operating USD 18,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap DividendsCommonStock Dividends, Common Stock USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001171843-17-001555
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -4.21 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001213900-24-021982
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.227 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent pure 0.104 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-13 0001213900-24-021982
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.003 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018373
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.011 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.081 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001213900-25-020368
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure -0.015 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001213900-25-020368
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure 0.016 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001213900-25-020368
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure 0.019 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.019 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 180,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-14 0001171843-18-001934
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 22,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability Embedded Derivative, Fair Value of Embedded Derivative Liability USD 1.40M 2013-09-04 2015 Q2 10-Q 2015-08-13 0001171843-15-004685
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 3.60M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 0 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap ExcessStockSharesAuthorized Excess Stock, Shares Authorized shares 10.00M 2021-03-31 2021 Q1 10-Q 2021-05-06 0001213900-21-024773
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-25 0001171843-14-005683
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 1.44M 2013-12-31 2014 FY 10-K 2015-03-20 0001171843-15-001528
us-gaap ForeignCurrencyContractsLiabilityFairValueDisclosure Foreign Currency Contracts, Liability, Fair Value Disclosure USD 537,000 2015-12-31 2016 FY 10-K 2017-03-16 0001171843-17-001555
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 66,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-14 0001171843-18-001934
us-gaap ForeignCurrencyTransactionGainLossRealized Foreign Currency Transaction Gain (Loss), Realized USD -61,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-14 0001171843-18-001934
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD 127,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-13 0001171843-19-001687
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 65,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-14 0001171843-16-008541
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 100,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-14 0001171843-16-008541
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 18.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap Goodwill Goodwill USD 29.52M 2021-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018373
us-gaap GoodwillFairValueDisclosure Goodwill, Fair Value Disclosure USD 29.50M 2021-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 29.52M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-13 0001213900-24-021982
us-gaap GoodwillWrittenOffRelatedToSaleOfBusinessUnit Goodwill, Written off Related to Sale of Business Unit USD 150,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 57.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 57.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 42,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -14.99M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -4.21 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.8 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-04 0001213900-23-036113
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares 0.48 2014-10-01 2014-12-31 2015 FY 10-K 2016-03-14 0001171843-16-008541
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-10-31 0001171843-19-007045
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 0 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-13 0001171843-19-001687
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 13.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 2.20M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-13 0001171843-19-001687
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 5,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -12.04M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 795,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 325,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 40,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 40,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 350,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 465,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap IncomeTaxReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount USD -1.31M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001171843-16-008541
us-gaap IncomeTaxReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount USD 1.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.08M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -2.50M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 1.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 77,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -2.95M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001171843-17-001555
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 81,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001171843-17-001555
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -923,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap IncreaseDecreaseInOperatingLiabilities Increase (Decrease) in Operating Liabilities USD 663,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-03 0001213900-23-062782
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 115,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001171843-17-001555
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -65,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001213900-21-024773
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -213,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001213900-21-056770
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 3.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -731,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001213900-24-096252
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -17,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap IncrementalCommonSharesAttributableToConversionOfPreferredStock Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock shares 8.03M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-03 0001213900-23-062782
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 3.07M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-03 0001213900-23-062782
us-gaap InterestAndOtherIncome Interest and Other Income USD 1.66M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-13 0001213900-26-055463
us-gaap InterestExpense Interest Expense USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 4.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -857,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001171843-17-001555
us-gaap InterestIncomeOther Interest Income, Other USD 2.47M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001213900-24-096252
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 34,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2014-12-31 2014 FY 10-K 2015-03-20 0001171843-15-001528
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 4.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap InvestmentIncomeNet Investment Income, Net USD 687,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-04 0001213900-23-036113
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 525,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 300,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-13 0001171843-19-001687
us-gaap LeaseCost Lease, Cost USD 1.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap LegalFees Legal Fees USD 24,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0001213900-22-045922
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 2.59M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 87,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0001213900-24-096252
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.43M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 87,000 2024-12-31 2024 FY 10-K 2025-03-05 0001213900-25-020368
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 87,000 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 87,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 718,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 357,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 155,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 0 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap Liabilities Liabilities USD 15.52M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 156.54M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap LiabilitiesCurrent Liabilities, Current USD 14.39M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment USD -5.15M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-20 0001171843-15-001528
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 537,000 2015-12-31 2016 FY 10-K 2017-03-16 0001171843-17-001555
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap LoansPledgedAsCollateral Loans Pledged as Collateral USD 22,000 2018-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap LossContingencyNewClaimsFiledNumber Loss Contingency, New Claims Filed, Number pure 4 2019-11-15 2019-12-23 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap MarketableSecurities Marketable Securities USD 88.86M 2025-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107881
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 101.90M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 16.03M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 45.35M 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 1.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 1.45M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-07 0001171843-17-004786
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 29.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -8.45M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-07 0001171843-17-004786
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -55.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -10.73M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-07 0001171843-17-004786
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -61.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -40.42M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001213900-24-021982
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 26.98M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001213900-22-069010
us-gaap NetInvestmentIncome Net Investment Income USD 17,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018373
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 4.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap NumberOfOperatingSegments Number of Operating Segments pure 1 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OperatingExpenses Operating Expenses USD 66.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -66.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 200,000 2019-01-01 2019-09-30 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.44M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.31M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.13M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.31M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 866,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 1.58M 2021-03-31 2021 Q1 10-Q 2021-05-06 0001213900-21-024773
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 159,000 2021-03-31 2021 Q1 10-Q 2021-05-06 0001213900-21-024773
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 229,000 2021-03-31 2021 Q1 10-Q 2021-05-06 0001213900-21-024773
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 224,000 2021-03-31 2021 Q1 10-Q 2021-05-06 0001213900-21-024773
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 220,000 2021-03-31 2021 Q1 10-Q 2021-05-06 0001213900-21-024773
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 216,000 2021-03-31 2021 Q1 10-Q 2021-05-06 0001213900-21-024773
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 532,000 2021-03-31 2021 Q1 10-Q 2021-05-06 0001213900-21-024773
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 1.11M 2020-12-31 2020 FY 10-K 2021-03-11 0001213900-21-014709
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.07 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 0 2017-08-02 2017 FY 10-K 2018-03-14 0001171843-18-001934
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.34M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OtherAssets Other Assets USD 6.21M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OtherAssetsCurrent Other Assets, Current USD 19,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 60,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -2,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap OtherComprehensiveIncomeLossBeforeTax Other Comprehensive Income (Loss), before Tax USD -477,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018373
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -640,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -39,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001213900-21-056770
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax USD -640,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -187,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OtherExpenses Other Expenses USD 3.24M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018373
us-gaap OtherLaborRelatedExpenses Other Labor-related Expenses USD 223,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018373
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 537,000 2015-12-31 2016 FY 10-K 2017-03-16 0001171843-17-001555
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 84,000 2015-09-30 2015 Q3 10-Q 2015-11-12 0001171843-15-006275
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 481,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 207,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 382,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 6.25M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-04 0001213900-23-036113
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Available-for-sale Securities USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-13 0001171843-19-001687
us-gaap PaymentsForOtherDeposits Payments for Other Deposits USD 1,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-20 0001171843-15-001528
us-gaap PaymentsForRent Payments for Rent USD 1.12M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001213900-25-020368
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 76,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-02 0001213900-24-038757
us-gaap PaymentsForRestructuring Payments for Restructuring USD 2.85M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 46,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-14 0001171843-16-008541
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 452,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001171843-17-001555
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 15.44M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 12.19M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-04 0001213900-23-036113
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD -3.72M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 74.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap PreferredStockAccretionOfRedemptionDiscount Preferred Stock, Accretion of Redemption Discount USD 1.30M 2014-10-01 2014-12-31 2015 FY 10-K 2016-03-14 0001171843-16-008541
us-gaap PreferredStockConvertibleConversionPrice PreferredStockConvertibleConversionPrice USD/shares 7.01 2024-12-31 2025 Q3 10-Q 2025-11-10 0001213900-25-107881
us-gaap PreferredStockConvertibleConversionRatio PreferredStockConvertibleConversionRatio pure 1,000 2024-12-31 2025 Q3 10-Q 2025-11-10 0001213900-25-107881
us-gaap PreferredStockConvertibleSharesIssuable PreferredStockConvertibleSharesIssuable shares 8,028 2021-12-31 2022 Q1 10-Q 2022-05-05 0001213900-22-024238
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 6.75M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-13 0001171843-19-001687
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2018-09-30 2018 Q3 10-Q 2018-11-07 0001171843-18-007677
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2018-09-30 2018 Q3 10-Q 2018-11-07 0001171843-18-007677
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 8 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036343
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 2.62M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 829,000 2015-09-30 2015 Q3 10-Q 2015-11-12 0001171843-15-006275
us-gaap PrepaidInsurance Prepaid Insurance USD 127,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap PrepaidRent Prepaid Rent USD 113,000 2020-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 500,000 2019-09-01 2019-09-23 2020 FY 10-K 2021-03-11 0001213900-21-014709
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 1.87M 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-04 0001213900-21-056770
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 1.87M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 73.57M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 25.32M 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-04 0001213900-21-056770
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 25.32M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 500,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-11 0001213900-21-014709
us-gaap ProceedsFromIssuanceOfRedeemablePreferredStock Proceeds from Issuance of Redeemable Preferred Stock USD 25.00M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001171843-17-001555
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 2.50M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap ProceedsFromRepaymentsOfShortTermDebt Proceeds from (Repayments of) Short-term Debt USD -1.30M 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-04 0001213900-21-056770
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 15.32M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-13 0001171843-15-004685
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 105.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 2.00M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 65,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-14 0001171843-16-008541
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 412,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 1,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107881
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -19.29M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0001213900-22-045922
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 200,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-14 0001171843-16-008541
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 2.23M 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.58M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap PropertyPlantAndEquipmentOther Property, Plant and Equipment, Other, Gross USD 613,000 2021-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 9,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap RepaymentsOfDebt Repayments of Debt USD 9,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-20 0001171843-15-001528
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 1.67M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 47.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap RestrictedCash Restricted Cash USD 50,000 2021-03-31 2022 Q1 10-Q 2022-05-05 0001213900-22-024238
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 34.51M 2023-09-30 2023 Q3 10-Q 2023-11-03 0001213900-23-083013
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 51.76M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001213900-24-096252
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 745,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0001213900-24-096252
us-gaap RestrictedCashAndInvestments Restricted Cash and Investments USD 745,000 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 50,000 2020-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 745,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap RestrictedStockExpense Restricted Stock or Unit Expense USD 915,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-03 0001213900-23-083013
us-gaap RestructuringCharges Restructuring Charges USD 2.85M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap RestructuringReserve Restructuring Reserve USD 1.02M 2019-09-30 2019 Q3 10-Q 2019-10-31 0001171843-19-007045
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -363.56M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap Revenues Revenues USD 2.95M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001171843-17-001555
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 6.55M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018373
us-gaap RoyaltyExpense Royalty Expense USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-12 0001171843-15-006275
us-gaap SecurityDeposit Security Deposit USD 22,000 2019-06-30 2019 Q3 10-Q 2019-10-31 0001171843-19-007045
us-gaap SeveranceCosts1 Severance Costs USD 2.90M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 4.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 9.18 2019-12-31 2020 FY 10-K 2021-03-11 0001213900-21-014709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001213900-26-025433
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.98 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001213900-21-024773
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.024 2019-01-01 2019-06-30 2020 Q2 10-Q 2020-07-31 0001213900-20-019642
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend USD 12.66M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 0.896 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 46,112 2024-03-31 2024 Q1 10-Q 2024-05-02 0001213900-24-038757
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 1.61M 2025-03-31 2025 Q1 10-Q 2025-05-08 0001213900-25-040811
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.36M 2025-03-31 2025 Q1 10-Q 2025-05-08 0001213900-25-040811
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 10.22 2025-03-31 2025 Q1 10-Q 2025-05-08 0001213900-25-040811
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 89,710 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001213900-25-020368
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 5,958 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0001213900-25-040811
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 706,004 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-07 0001171843-17-004786
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.06M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0001213900-25-040811
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 2.99 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001213900-24-021982
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 2.28 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0001213900-25-040811
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 204,438 2022-09-30 2022 Q3 10-Q 2022-11-03 0001213900-22-069010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 4.22M 2025-03-31 2025 Q1 10-Q 2025-05-08 0001213900-25-040811
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 4.91M 2025-03-31 2025 Q1 10-Q 2025-05-08 0001213900-25-040811
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.71 2025-03-31 2025 Q1 10-Q 2025-05-08 0001213900-25-040811
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 4.91M 2025-03-31 2025 Q1 10-Q 2025-05-08 0001213900-25-040811
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 6.71 2025-03-31 2025 Q1 10-Q 2025-05-08 0001213900-25-040811
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 4.22M 2025-03-31 2025 Q1 10-Q 2025-05-08 0001213900-25-040811
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 111 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 218.4 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 12.6 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.45 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-14 0001171843-18-001934
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 12.97 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001213900-25-020368
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 2.83 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001213900-25-020368
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 4.53 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0001213900-25-040811
us-gaap SharesIssued Shares, Issued shares 69,114 2019-09-23 2020 FY 10-K 2021-03-11 0001213900-21-014709
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 7.23 2019-09-23 2020 FY 10-K 2021-03-11 0001213900-21-014709
us-gaap SharesOutstanding Shares, Outstanding shares 557,631 2020-01-09 2020 Q1 10-Q 2020-05-13 0001213900-20-011893
us-gaap ShortTermBorrowings Short-term Debt USD 370,793 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036343
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 3,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-13 0001213900-24-021982
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 141.02M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 47,580 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001213900-25-020368
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 34.53M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 126.84M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001171843-17-001555
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 132,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 73.57M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001213900-21-014709
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 11.09M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001213900-21-014709
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 12.41M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 26,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 4.88M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001213900-24-021982
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 412,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 3.73M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-03 0001213900-23-083013
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 3.60M 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 6.35M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001171843-17-001555
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 6.35M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001171843-17-001555
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 35.42M 2014-09-30 2014 Q3 10-Q 2014-11-25 0001171843-14-005683
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD -81,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-25 0001171843-14-005683
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2019-12-31 2019 FY 10-K 2020-03-20 0001171843-20-001860
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-14 0001171843-18-001934
us-gaap USGovernmentSecuritiesAtCarryingValue US Government Securities, at Carrying Value USD 9.99M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001213900-24-096252
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 27.80M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap VariableLeaseCost Variable Lease, Cost USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 11.69M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-03 0001213900-23-062782
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 60.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 11.23M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-09 0001213900-22-011208
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 60.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001213900-26-116612

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →